SEC 13F Intelligence

Checkpoint Capital L.P. / MIRM

Checkpoint Capital L.P.’s Mirum Pharmaceuticals Inc Position

Does Checkpoint Capital L.P. own Mirum Pharmaceuticals Inc (MIRM)? Not currently — the last reported position was 362.2K shares worth $9M in Q1 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$9M
Q1 2024
Shares
362.2K
% of Portfolio
+6.08%
Quarters Held
2
position exited

Position History MIRM

Reported value by quarter
Q4 ’23: $7MQ4 ’23Q1 ’24: $9MQ1 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2024362.2K$9M+6.08%
Q4 2023233.7K$7M+4.18%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Checkpoint Capital L.P.’s full portfolio or all institutional holders of MIRM.